Surface Oncology, Inc.
Antibodies That Bind CD39 and Uses Thereof
Last updated:
Abstract:
The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
Status:
Application
Type:
Utility
Filling date:
13 Mar 2019
Issue date:
25 Nov 2021